
In the rapidly evolving landscape of digital healthcare, securing funding can be the game changer that propels innovative startups into the spotlight. Recently, Foresight Group, a prominent player in private equity and infrastructure investment, announced a substantial £3.0 million investment in MyWay Digital Health Ltd (MWDH), a trailblazer in digital health solutions particularly focusing on managing chronic conditions like diabetes. This strategic partnership is set to accelerate MWDH's product development and expand its global reach, making a significant impact on the healthcare sector.
Founded in 2017 as a spin-out from the University of Dundee, MWDH is dedicated to enhancing the lives of individuals living with long-term health conditions through innovative, data-driven solutions.
The company currently employs 30 staff across key UK cities, including Dundee, Edinburgh, and London. With a mission to offer cost-effective, personalized health technology, MWDH's flagship product, MyWay Diabetes, serves as a clinically validated digital self-management tool. By integrating with NHS systems, it delivers personalized education, data visualization, and actionable insights, all of which contribute to improved patient engagement and health outcomes across multiple NHS regions and beyond.
According to Debbie Wake, CEO and Co-Founder of MWDH, “We are delighted to have secured investment from Foresight, marking a significant milestone in MWDH’s journey." The funding will enable the company to accelerate its growth strategy, broaden its product portfolio, and enhance its global footprint at a time when the demand for scalable digital health solutions is surging. With the addition of Dr. Umang Patel as Non-Executive Chair, who brings invaluable experience from the technology and healthcare sectors, MWDH is poised to drive innovative developments, including AI-enabled products and personalized care pathways, to meet the evolving needs of the market.
Click here for a full list of 7,526+ startup investors in the UK